Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
about
Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trialsThe human plasma lipidomeThe relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic diseaseMetabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammationDiscovery and fine-mapping of loci associated with MUFAs through trans-ethnic meta-analysis in Chinese and European populations.Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) conPalmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesisGenetic correlation of the plasma lipidome with type 2 diabetes, prediabetes and insulin resistance in Mexican American families.Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.De Novo Lipogenesis Products and Endogenous Lipokines.Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.Early life stress interacts with the diet deficiency of omega-3 fatty acids during the life course increasing the metabolic vulnerability in adult rats.Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study.The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity.MUFAsYin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolismRed Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory StudyGluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humansLong-term effect of early postnatal overnutrition on insulin resistance and serum fatty acid profiles in male rats.Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease.Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositolThe inflammation highway: metabolism accelerates inflammatory traffic in obesity.Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health StudyEstimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) studyPlasma phospholipid concentration of cis-palmitoleic acid and risk of heart failureHepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague-Dawley rats.High dairy fat intake related to less central obesity: a male cohort study with 12 years' follow-upEthnic- and sex-specific associations between plasma fatty acids and markers of insulin resistance in healthy young adults.Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.A novel AhR ligand, 2AI, protects the retina from environmental stress.Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians.An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus.Fat sensing and metabolic syndrome.Lipid chaperones and metabolic inflammation.
P2860
Q26828572-ACCCA866-69E4-4E11-83EA-A02590744720Q26830940-B0FD3E36-4FE8-42A8-9CF5-77AF398BB065Q28271342-053516A9-E045-4F56-BF2C-DD08A68549C6Q28728589-7C1E9DF5-8C05-4F33-8065-3481AA8250C1Q30252943-CDC9E5CF-8B96-4350-9FBA-56A2F6BEC301Q30413971-DD189346-ED33-44FB-BCF4-2599BE5C339CQ30881258-754F9156-DF60-4E8C-A9C4-8EBA3602C351Q33709055-BD76737A-B819-4E67-9D5F-1DB9509FE51AQ34328111-B1FE03D5-1D0E-4745-B10F-5E27E98BE59BQ34468157-84D9CD45-BBD7-4895-8A2C-3B1D7BE0CCF7Q34530470-9EEE4D7F-5967-4AA9-B695-1713D8206962Q34667064-B67FEB59-08CD-4F11-9154-03EFEB30EA3DQ34685518-8D907577-C6AD-419F-926C-31A272B8B6F2Q34706584-133B3EED-9428-4D0B-A6C3-872A82125736Q35042217-4351E4E7-35B0-46E2-BB6E-8F052E1DEC49Q35087097-96F7F703-5921-4463-B384-06E5DFD037CDQ35125333-DC47DC01-6A97-4D5A-9899-A51C2802DE87Q35537840-246FEA50-4189-4421-B992-4BFE26542E62Q35538813-57F5DE31-93CA-4DEA-BEC2-1F01B46D9AE7Q35584643-1F207C42-D9D7-4A6B-B81E-E4E3F87E5BEBQ35659559-CF12D787-5790-49D6-9D60-E1C71AE4610DQ35924961-9369629C-9C99-4490-AA0E-4DF556D70EE9Q35976776-377DD647-0DB9-431F-9332-A27AE33A4C75Q35995225-6947EECE-B64F-41C6-A5F6-5528C92AC1CCQ36129469-F102787A-20A1-4B1C-A952-389684987FC1Q36137547-B80AE851-5B26-484B-BDE1-8C3013F37C2AQ36174974-1FBA3849-362B-4698-95EE-53D4E276599EQ36317134-7642E703-2849-4175-998F-41B8D30938A0Q36398318-4D5AE021-7067-48F9-AC54-222FCBC796F3Q36456941-826ABC21-9EFB-40C1-A266-C3B432F0537EQ36745307-1E52A5F6-4663-49CF-AAE7-D749C3B1209BQ36803858-F2CF05AE-ECF0-42FC-9A18-D88317385D32Q36850679-DD679F4E-513A-4054-AF96-B1B4C12CA198Q36940461-0CBF773C-1150-4858-926E-1973099320A9Q36997973-AB6A52F7-AE74-4C14-A685-2E17DC8CB808Q37057482-2210B778-9CEC-43CE-9184-08C3A43B610EQ37365774-23EF9408-CCBD-48B1-A98D-E4E45E9B4EB6Q37441548-6BD8B376-CAD0-4D3D-B193-1B923F21A0C4Q38262627-B4B48734-4C07-410C-96A1-E456CAD8A365Q38908903-F296DF64-F3FF-466C-A1E1-21168CBD6DB7
P2860
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@ast
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@en
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@nl
type
label
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@ast
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@en
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@nl
prefLabel
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@ast
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@en
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@nl
P2093
P2860
P356
P1476
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
@en
P2093
Gökhan S Hotamisligil
Haiming Cao
Irena B King
Rozenn N Lemaitre
Xiaoling Song
P2860
P304
P356
10.3945/AJCN.110.003970
P407
P577
2010-10-13T00:00:00Z